title: Course of FEV(1) after onset of bronchiolitis obliterans syndrome in lung transplant recipients.
abstract: BACKGROUND
  Bronchiolitis obliterans syndrome (BOS), defined by loss of lung function, develops in the majority of lung transplant recipients. However, there is a paucity of information on the subsequent course of lung function in these patients.
  
  
  OBJECTIVE
  To characterize the course of FEV(1) over time after development of BOS and to determine the predictors that influence the rate of functional decline of FEV(1).
  
  
  METHODS
  FEV(1)% predicted (FEV(1)%pred) trajectories were studied in 111 lung transplant recipients with BOS by multivariate, linear, mixed-effects statistical models.
  
  
  RESULTS
  FEV(1)%pred varied over time after BOS onset, with the steepest decline typically seen in the first 6 months (12% decline; p < 0.0001). Bilateral lung transplant recipients had significantly higher FEV(1)%pred at BOS diagnosis (71 vs. 47%; p < 0.0001) and at 24 months after BOS onset (58 vs. 41%; p = 0.0001). Female gender and pretransplant diagnosis of idiopathic pulmonary fibrosis were associated with a steeper decline in FEV(1)%pred in the first 6 months after BOS diagnosis (p = 0.02 and 0.04, respectively). A fall in FEV(1) greater than 20% in the 6 months preceding BOS (termed "rapid onset") was associated with shorter time to BOS onset (p = 0.01), lower FEV(1)%pred at BOS onset (p < 0.0001), steeper decline in the first 6 months (p = 0.03), and lower FEV(1)%pred at 2 years after onset (p = 0.0002).
  
  
  CONCLUSIONS
  Rapid onset of BOS, female gender, pretransplant diagnosis of idiopathic pulmonary fibrosis, and single-lung transplantation are associated with worse pulmonary function after BOS onset.
authors.affiliation: Division of Pulmonary and Critical Care Medicine, University of Michigan Health System, 1500 East Medical Center Drive, 3916 Taubman Center, Ann Arbor, MI 48109-0360, USA. vlama@umich.edu
authors.forename: Vibha N
authors.initials: VN
authors.lastname: Lama
authors.forename: Susan
authors.initials: S
authors.lastname: Murray
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Lonigro
authors.forename: Galen B
authors.initials: GB
authors.lastname: Toews
authors.forename: Andrew
authors.initials: A
authors.lastname: Chang
authors.forename: Christine
authors.initials: C
authors.lastname: Lau
authors.forename: Andrew
authors.initials: A
authors.lastname: Flint
authors.forename: Kevin M
authors.initials: KM
authors.lastname: Chan
authors.forename: Fernando J
authors.initials: FJ
authors.lastname: Martinez
mesh_terms: D000328:Adult; D001706:Biopsy; D001980:Bronchi / Q000473:pathology; D001989:Bronchiolitis Obliterans / Q000209:etiology / Q000473:pathology / Q000503:physiopathology*; D003937:Diagnosis, Differential; D018450:Disease Progression; D005260:Female; D005500:Follow-Up Studies; D005541:Forced Expiratory Volume / Q000502:physiology; D006801:Humans; D006976:Hypertension, Pulmonary / Q000601:surgery; D016040:Lung Transplantation / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D011379:Prognosis; D011656:Pulmonary Emphysema / Q000601:surgery; D012189:Retrospective Studies; D012720:Severity of Illness Index; D013577:Syndrome; D013997:Time Factors